OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting focal adhesion kinase (FAK) for cancer therapy: FAK inhibitors, FAK-based dual-target inhibitors and PROTAC degraders
Ming Yang, Hua Xiang, Guoshun Luo
Biochemical Pharmacology (2024) Vol. 224, pp. 116246-116246
Closed Access | Times Cited: 12
Ming Yang, Hua Xiang, Guoshun Luo
Biochemical Pharmacology (2024) Vol. 224, pp. 116246-116246
Closed Access | Times Cited: 12
Showing 12 citing articles:
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Targeting Focal adhesion kinase (FAK) in cancer therapy: A recent update on inhibitors and PROTAC degraders
Xiao Wang, Na Li, Yunhe Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116678-116678
Closed Access | Times Cited: 9
Xiao Wang, Na Li, Yunhe Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116678-116678
Closed Access | Times Cited: 9
Discovery of Noncovalent Diaminopyrimidine-based Inhibitors for Glioblastoma via a Dual FAK/DNA Targeting Strategy
Yi Wei, Xiaoling He, Zhiwu Long, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117288-117288
Closed Access
Yi Wei, Xiaoling He, Zhiwu Long, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117288-117288
Closed Access
Molecular modeling aided design, synthesis and biological evaluation of quinazoline derivatives for the treatment of human cancer
Cai‐Shi Liu, Jin-Peng Tong, Zheng Fang, et al.
Molecular Diversity (2025)
Closed Access
Cai‐Shi Liu, Jin-Peng Tong, Zheng Fang, et al.
Molecular Diversity (2025)
Closed Access
Focal adhesion in the tumour metastasis: from molecular mechanisms to therapeutic targets
Zonghao Liu, Xiaofang Zhang, Theresa Ben, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Zonghao Liu, Xiaofang Zhang, Theresa Ben, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Carnosol mitigates Ang II-stimulated vascular injury and oxidative stress by directly binding to FAK and inhibiting its activation
Yucheng Jiang, Zhaozheng Zheng, Junyi Wang, et al.
Inflammopharmacology (2025)
Closed Access
Yucheng Jiang, Zhaozheng Zheng, Junyi Wang, et al.
Inflammopharmacology (2025)
Closed Access
Design, synthesis and biological evaluation of coumarin-containing 2,4-diphenylpyrimidine derivatives as novel focal adhesion kinase inhibitors for treatment of non-small cell lung cancer
Mengrong Lei, Hanxue Huang, Jiayi Li, et al.
Bioorganic & Medicinal Chemistry Letters (2025), pp. 130240-130240
Closed Access
Mengrong Lei, Hanxue Huang, Jiayi Li, et al.
Bioorganic & Medicinal Chemistry Letters (2025), pp. 130240-130240
Closed Access
Focal adhesion kinase (FAK): emerging target for drug-resistant malignant tumors
Jaya Aakriti, Megh Pravin Vithalkar, Swastika Maity, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Open Access
Jaya Aakriti, Megh Pravin Vithalkar, Swastika Maity, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Open Access
LncRNA FAISL Inhibits Calpain 2‐Mediated Proteolysis of FAK to Promote Progression and Metastasis of Triple Negative Breast Cancer
Yunmei Zhang, Shiyu Wei, Zhengjie Chen, et al.
Advanced Science (2024)
Open Access | Times Cited: 1
Yunmei Zhang, Shiyu Wei, Zhengjie Chen, et al.
Advanced Science (2024)
Open Access | Times Cited: 1
Targeting a key FAK-tor: the therapeutic potential of combining focal adhesion kinase (FAK) inhibitors and chemotherapy for chemoresistant non-small cell lung cancer
Emma Geijerman, Francesca Terrana, Godefridus J. Peters, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 11, pp. 1103-1118
Closed Access | Times Cited: 1
Emma Geijerman, Francesca Terrana, Godefridus J. Peters, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 11, pp. 1103-1118
Closed Access | Times Cited: 1
Advancements in Protein Degradation for Cancer Therapy
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 7, pp. 998-1000
Open Access
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 7, pp. 998-1000
Open Access
Computational Approaches to Identifying Potent FAK Inhibitors: A Molecular Docking and Toxicity Study
Surbhi Singh, Vaibhav Nigam, Preeti Patel
International Journal of Newgen Research in Pharmacy & Healthcare (2024), pp. 59-65
Closed Access
Surbhi Singh, Vaibhav Nigam, Preeti Patel
International Journal of Newgen Research in Pharmacy & Healthcare (2024), pp. 59-65
Closed Access
Focal adhesion kinase as a new player in the biology of onco-hematological diseases: the starting evidence
Guido Capasso, Nayla Mouawad, Maria Castronuovo, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Guido Capasso, Nayla Mouawad, Maria Castronuovo, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
